Assessing lung recruitment in preterm infants using echocardiography and ultrasound

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of high frequency oscillatory ventilation (HFOV) in improving lung recruitment in preterm infants aged 32 to 37 weeks with moderate to severe respiratory distress. It also compares the use of chest ultrasound for monitoring lung recruitment against traditional chest x-rays. Additionally, the study assesses cardiac hemodynamics through functional echocardiography to provide a comprehensive evaluation of the infants' respiratory and cardiac status.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Infants will be enrolled if they are 32 to 37 weeks of gestational age, have respiratory distress (RD) in the first 24 h of life, intubated and have invasive respiratory support using HFOV. Signs of RD are tachypnea (respiratory rate \> 60/min), grunting, nasal flaring, chest retraction, and need of oxygen supplementation or other respiratory support.

Exclusion Criteria:

1. Known major congenital anomalies including congenital heart diseases.
2. Fetal hydrops.
3. Babies with congenital heart diseases

Where it's running

• Marwa Mohamed Farag
  Alexandria, Egypt Recruiting
• Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
  Alexandria, Egypt Not yet recruiting

Study contacts

• Study coordinator: Marwa M Farag, PhD
• Email: d.marwa.farag@gmail.com
• Phone: 01288681788

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Single-beat TE-e' for estimating left atrial pressure in critically ill patients

  A noninvasive test using a single-beat TE-e' echocardiography measurement is being tried to see if it can reliably indicate elevated left atrial pressure in critically ill adults.

  Recruiting Queen Mary Hospital, Hong Kong · Hong Kong · NCT07820319

• Automated Echocardiography Measurements Using Deep-Learning Software

  This study tests whether US2.AI can automatically measure heart structure and function from standard echocardiograms as accurately as expert clinicians in adults.

  Recruiting Centro Cardiologico Monzino · Milan, Lombardy · NCT07738419

• Cardiac and carotid ultrasound reference values in healthy children in Italy

  This study tests heart and artery measurements to establish normal reference values for healthy kids in Italy.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07666451

• DigitHeart Echo: predicting heart ultrasound findings from a smartphone photo of your ECG

  This test checks whether a smartphone app can predict echocardiogram findings from a photo of a 12‑lead ECG in adults scheduled for echocardiography.

  Recruiting The University of Hong Kong · Hong Kong · NCT07558109

• COMA.NET: Targeted treatment for coronary microcirculation problems

  This trial will test whether tailoring medicines based on intracoronary microvascular testing improves quality of life for people with ischemia but no large artery blockages.

  Recruiting Medical University of Bialystok · Bialystok · NCT07498231

• Global longitudinal strain to predict difficult separation from cardiopulmonary bypass

  This will test whether a heart ultrasound measure called global longitudinal strain (GLS) can predict which adults having elective cardiac surgery will have trouble coming off cardiopulmonary bypass.

  Recruiting at 2 sites Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital · Rome and 1 other locations · NCT07390903

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.